© Copyright 2012, vLex. All Rights Reserved.
- Language
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Arthritis Research Campaign
548 documents for Arthritis Research Campaign
-
WASHINGTON and DEERFIELD, Ill., June 28, 2011 /PRNewswire/ -- Men's Health Network (MHN) and Takeda Pharmaceuticals North America, Inc., today announced a partnership to launch the "Gout Pit Stop," an educational campaign to raise awareness about gout, a type of arthritis that affects approximately 8.3 million people in the U.S. and is the most common form of inflammatory arthritis in men. Launched just before one of the biggest events of the year on the racing calendar and during Men's Health Month, the national campaign will inform people about gout and its underlying cause and encourage them to speak with their healthcare provider about ways to manage it to help avoid painful flares. The campaign, which also includes a sweepstakes, invites people to learn more by making their own "Go...
...and Takeda Global Research & Development Center, Inc. Based in Deerfield, Ill...
-
... forefront of immunology treatment and research, is marking the 2011 American College of Rheumatol... to people living with rheumatoid arthritis (RA) and their healthcare providers. At this year'...: Finding a Cure for Rheumatoid Arthritis Campaign: UCB is a Pinnacle donor of the $30-plus million A...
-
... pustular, plaque or psoriatic arthritis. Of all the currently available biologics, etanerc... these drugs in pediatric psoriasis, much research has been focused on the use of biologic agents in ...
-
... Naproxen in Patients with Rheumatoid Arthritis, 343 New England J. Medicine 1520, 1523, 1526–15... Merck, claiming that “Merck’s own research” had demonstrated that “users of Vioxx were four ... it found that Merck’s “promotional campaign selectively present[ed]” that hypothesis without...
-
Traditional treatment with corticosteroids and disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, treat pain and inflammation, but these compounds have serious side effects, including toxicity and immunosuppression. The patients treated with rituximab exhibited less fatigue, higher health-related quality of life, and a trend of slower progression of joint structural damage as measured by radiographic progression. In addition, a better understanding of the mechanism of action behind various autoimmune diseases and potential therapies could lead to dividing the patients into treatment groups that, says Anolik, "may respond to different therapies, and predict response to treatment.
...Paul Emery, Arthritis Research Campaign Professor of Rheumatology at the...
-
...According to the Arthritis Research Campaign, approximately 1 in 50 people have psoria...
-
... be provided by the Wellcome Trust, the Arthritis Research Campaign, the Association of Medical Rese...
-
... Clinical Benchmarks (ECB)([R]), the research and academic arm of MedRisk, Inc. Main is a profes..., specializing in pain management in the Arthritis Research Campaign National Primary Care Centre at ...
-
...31 March 2011- Minister Welcomes Arthritis Awareness Week 2011-Chronic conditions involving t... Break the Chain: Indigenous Anti Tobacco Campaign Kicks Off-A new advertising campaign urging Indige...Australian National Health & Medical Research Council Tracker - 25 March 2011 edition . Australi...
-
...According to the Arthritis Research Campaign, approximately 1 in 50 people have psoria...
